Related Experiment Video
Updated: Jun 14, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Gene expression profiling identifies STAT3 as a novel pathway for immunomodulation by cholera toxin adjuvant
A Sjöblom-Hallén1, U Marklund, A Nerstedt
1Department of Microbiology and Immunology, Institute of Biomedicine, Mucosal Immunobiology and Vaccine Center (MIVAC), Gothenburg, Sweden.
Abstract:
Earlier studies have reported on both proinflammatory and anti-inflammatory activities of cholera toxin (CT). As CT is a powerful adjuvant, we were interested in identifying genes with a possible involvement in these functions. A global gene expression analysis in mouse B cells showed that CT regulated <100 annotated genes, which encoded transcription factors, G proteins, cell-cycle regulators, and immunoregulating molecules. Interestingly, CT regulated the expression of the signal transducer and activator of transcription (STAT)3 gene and influenced the level and activation of both isoforms STAT3 alpha and STAT3 beta, in vitro in a B-cell line and in Peyer's patch (PP) B cells and in vivo in freshly isolated splenic B cells from CT-treated mice. This effect was cAMP dependent and was not seen with CTB. B cells pre-exposed to CT were significantly more susceptible to the activation of STAT3 by interleukin (IL)-6 and IL-10. This exerted a stronger inhibitory effect of IL-10 on lipopolysaccharide (LPS)-stimulated B-cell proliferation and cytokine production (IL-6). Moreover, IgG1 and IgA production induced by LPS and IL-10 were enhanced by the addition of CT to cultures of PP or splenic B cells. This is the first study to provide a molecular mechanism that can reconcile previous findings of proinflammatory and anti-inflammatory effects by CT adjuvant.
Insights
Cholera toxin (CT) regulates STAT3 in B cells, influencing immune responses. This provides a molecular mechanism for CT's dual pro- and anti-inflammatory effects as an adjuvant.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Cholera toxin (CT) exhibits both pro-inflammatory and anti-inflammatory activities.
- CT is a potent immune adjuvant, necessitating investigation into its underlying molecular mechanisms.
- Previous studies have yielded conflicting results regarding CT's immunomodulatory effects.
Purpose of the Study:
- To identify genes involved in the pro- and anti-inflammatory functions of CT.
- To elucidate the molecular mechanism by which CT influences B cell responses.
- To reconcile the disparate findings on CT's adjuvant properties.
Main Methods:
- Global gene expression analysis in mouse B cells treated with CT.
- Investigation of signal transducer and activator of transcription (STAT)3 expression and activation in B cells (in vitro and in vivo).
- Assessment of B cell responses to interleukin (IL)-6 and IL-10 following CT pre-exposure, including proliferation and cytokine production.
Main Results:
- CT regulated fewer than 100 annotated genes in mouse B cells, including STAT3.
- CT increased STAT3 expression and activation in a cAMP-dependent manner, independent of CTB.
- CT-exposed B cells showed enhanced STAT3 activation by IL-6 and IL-10, leading to increased IgG1 and IgA production and altered IL-10 effects on LPS-stimulated B cells.
Conclusions:
- CT modulates STAT3 signaling in B cells, providing a molecular basis for its dual immunomodulatory effects.
- This study reconciles previous observations of CT's pro- and anti-inflammatory roles.
- CT's adjuvant activity is linked to its influence on STAT3 pathways and subsequent B cell responses.
Related Concept Videos
The JAK-STAT Signaling Pathway
Regulation of Bacterial Virulence
Constitutive and Regulated Gene Expression
Regulation of Expression at Multiple Steps
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
